Zhang Dingshan, Chen Li, Maryam Mazhar, Xue Jinyi, Liu Ping, Liu Mengnan
{"title":"Application of promoting blood circulation and resolving blood stasis in intracerebral hemorrhage: a traditional method gradually being reconsidered.","authors":"Zhang Dingshan, Chen Li, Maryam Mazhar, Xue Jinyi, Liu Ping, Liu Mengnan","doi":"10.19852/j.cnki.jtcm.2025.02.017","DOIUrl":null,"url":null,"abstract":"<p><p>Intracerebral hemorrhage (ICH) is a significant and growing threat to human health, with increasing incidence. Promoting blood circulation and removing blood stasis therapy (PBCRBS), a Traditional Chinese Medicine therapy, can be an adjuvant therapy to benefit patients with ICH by improving clinical efficacy. However, in theory, using PBCRBS to treat ICH carries the risk of hematoma enlargement and rebleeding, which has led to controversy over its application in ICH treatment. To demonstrate the effectiveness and safety of PBCRBS in treating ICH, this review first analyzes the pathological and physiological basis of ICH and secondly, the cascade of response after ICH and the involvement of cytokines and signaling pathways in this process. Finally, experimental and clinical studies on the treatment of ICH with PBCRBS over the past decade were retrieved from the PubMed and China National Knowledge Infrastructure databases, and the content of these studies was used to summarize commonly used herbs with PBCRBS effects and their mechanisms of action. Through analysis, hypertension has been identified as the most common cause of ICH. Heme, interleukin, reactive oxygen species, coagulation promoting particles and other induced mass effects, inflammation, oxidative stress, and coagulation cascade reactions lead to brain damage following ICH. This review includes 56 experimental studies and 83 clinical studies summarizing 28 commonly used herbs, demonstrating the positive impact of PBCRBS as an adjuvant therapy for ICH. In summary, PBCRBS appears effective and safe for treating ICH.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"45 2","pages":"458-472"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11955772/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19852/j.cnki.jtcm.2025.02.017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Intracerebral hemorrhage (ICH) is a significant and growing threat to human health, with increasing incidence. Promoting blood circulation and removing blood stasis therapy (PBCRBS), a Traditional Chinese Medicine therapy, can be an adjuvant therapy to benefit patients with ICH by improving clinical efficacy. However, in theory, using PBCRBS to treat ICH carries the risk of hematoma enlargement and rebleeding, which has led to controversy over its application in ICH treatment. To demonstrate the effectiveness and safety of PBCRBS in treating ICH, this review first analyzes the pathological and physiological basis of ICH and secondly, the cascade of response after ICH and the involvement of cytokines and signaling pathways in this process. Finally, experimental and clinical studies on the treatment of ICH with PBCRBS over the past decade were retrieved from the PubMed and China National Knowledge Infrastructure databases, and the content of these studies was used to summarize commonly used herbs with PBCRBS effects and their mechanisms of action. Through analysis, hypertension has been identified as the most common cause of ICH. Heme, interleukin, reactive oxygen species, coagulation promoting particles and other induced mass effects, inflammation, oxidative stress, and coagulation cascade reactions lead to brain damage following ICH. This review includes 56 experimental studies and 83 clinical studies summarizing 28 commonly used herbs, demonstrating the positive impact of PBCRBS as an adjuvant therapy for ICH. In summary, PBCRBS appears effective and safe for treating ICH.
脑出血(ICH)是威胁人类健康的重大疾病,其发病率越来越高。活血化瘀中药疗法(PBCRBS)作为一种辅助疗法,可以提高 ICH 患者的临床疗效。然而,从理论上讲,活血化瘀疗法治疗 ICH 有血肿扩大和再出血的风险,因此在 ICH 治疗中的应用存在争议。为了证明 PBCRBS 治疗 ICH 的有效性和安全性,本综述首先分析了 ICH 的病理和生理基础,其次分析了 ICH 后的级联反应以及细胞因子和信号通路在这一过程中的参与。最后,从 PubMed 和中国国家知识基础设施数据库中检索了近十年来用 PBCRBS 治疗 ICH 的实验和临床研究,并根据这些研究的内容总结了具有 PBCRBS 作用的常用中草药及其作用机制。通过分析发现,高血压是导致 ICH 的最常见原因。血红素、白细胞介素、活性氧、促凝微粒和其他诱发的质量效应、炎症、氧化应激和凝血级联反应导致 ICH 后的脑损伤。本综述包括 56 项实验研究和 83 项临床研究,总结了 28 种常用草药,证明了 PBCRBS 作为 ICH 辅助疗法的积极影响。总之,PBCRBS 似乎对治疗 ICH 既有效又安全。